TRIPASS XR تري باس

 

9. Ramasethu J, Luban NLC. Alloimmune hemolytic disease of the

newborn. In: Kaushansky K, Lichtman MA, Beutler E, et al., eds.

Williams’ Hematology. 8th ed. New York: McGraw-Hill; 2010:799.

10. Naulaers G, Barten S, Vanhole C, et al. Management of severe

neonatal anemia due to fetomaternal transfusion. Am J Perinatol.

1999;16:193.

11. Ozek E, Soll R, Schimmel MS. Partial exchange transfusion to

prevent neurodevelopmental disability in infants with polycythemia. Cochrane Database Syst Rev. 2010;20:CD005089.

12. Sugiura T, Goto K, Nichonji T et al. Cytokine profiles before and

after exchange transfusion in a neonate with transient myeloproliferative disorder and hepatic fibrosis. J Pediatr Hematol Oncol.

2010;32:e164.

13. Park ES, Kim SY, Yeom JS, et al. Extreme thrombocytosis associated with transient myeloproliferative disorder with Down syndrome with t(11;17)(q13;q21). Pediatr Blood Cancer. 2008;50:

643.

14. Rand EB, Karpen SJ, Kelly S, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr. 2009;155:566.

15. Chen CY, Chen YC, Fang JT, et al. Continuous arteriovenous

hemodiafiltration in the acute treatment of hyperammonemia

due to ornithine transcarbamylase deficiency. Ren Fail. 2000;

22:823.